InvestSMART

Genetic Signatures Limited (ASX:GSS)

ALERT: Price-sensitive ASX Announcement for GSS
Current share price for GSS : $0.067 -0.193 (-74.23%)+
Announcement
Release
15 Dec 2025 9:27AM
Price at Release
$0.260
Full Release
download
Summary
Genetic Signatures Limited announced that their CEO, Ms. Allison Rossiter, will be leaving the company in February 2026 to join a global pharmaceutical company. The Board has commenced a search for a new CEO and will implement interim leadership arrangements. Dr. Jenny Harry and Ms. Anne Lockwood will support the management team during this period, with additional support from U.S.-based Directors for U.S. sales activities. The outgoing CEO expressed gratitude for the opportunity to lead the company and confidence in its future success. The company is also progressing with the recruitment for a CFO. These leadership changes aim to strengthen the management team and enhance market opportunities in the U.S.
Key Points
  • CEO Allison Rossiter is leaving Genetic Signatures in February 2026.
  • The Board is searching for a new CEO.
  • Interim leadership will be supported by Dr. Jenny Harry and Ms. Anne Lockwood.
  • U.S.-based Directors will assist with U.S. sales activities.
  • The company is also recruiting a new CFO.
  • Leadership changes aim to strengthen management and U.S. market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.